Strengthening life-course immunisation in migrant populations: access, equity, and inclusion.

Catch-up vaccination Health inequalities Life-course vaccination Migrant health Vaccine acceptance and demand

Journal

The Lancet regional health. Europe
ISSN: 2666-7762
Titre abrégé: Lancet Reg Health Eur
Pays: England
ID NLM: 101777707

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 11 07 2023
revised: 14 11 2023
accepted: 20 11 2023
medline: 9 8 2024
pubmed: 9 8 2024
entrez: 9 8 2024
Statut: epublish

Résumé

Adult and adolescent migrants worldwide, and those arriving in Europe, are an under-immunised group for routine vaccinations due to missed childhood vaccines and doses in their countries of origin, and their subsequent marginalisation from health and vaccination systems. Declining population-level coverage for routine vaccines across Europe, which has accelerated post-pandemic, places these and other under-immunised populations at even greater risk of vaccine-preventable diseases. However, despite clear guidelines around the importance of delivering 'catch-up' vaccination throughout the life-course, migrants are rarely effectively incorporated into routine vaccination programmes on arrival to Europe. These populations have subsequently been involved in outbreaks, including measles and diphtheria, and are missing opportunities to receive more recently introduced vaccines such as HPV to align them with European vaccine schedules. WHO's new Immunization Agenda 2030 places a renewed emphasis on equitable access to vaccine systems and integrating catch-up vaccination for missed vaccines and doses throughout the life-course. In addition, lessons learned and innovations from the COVID-19 pandemic merit further consideration in the design and delivery of more inclusive vaccination programmes. We describe current gaps in policy and practice around life-course vaccination in migrant populations, key factors that drive low vaccine uptake and coverage, and explore the benefits of participatory approaches to designing and delivering interventions with impacted communities, to define new strategies to advance vaccine equity across the Region.

Identifiants

pubmed: 39119098
doi: 10.1016/j.lanepe.2023.100806
pii: S2666-7762(23)00225-9
pmc: PMC11306209
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

100806

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023 The Author(s).

Déclaration de conflit d'intérêts

All authors declare no conflicts of interest.

Auteurs

Felicity Knights (F)

The Migrant Health Research Group, Institute for Infection and Immunity, St George's University of London, London, UK.
The Lancet Migration European Regional Hub, UK.

Jessica Carter (J)

The Migrant Health Research Group, Institute for Infection and Immunity, St George's University of London, London, UK.
The Lancet Migration European Regional Hub, UK.

Anna Deal (A)

The Migrant Health Research Group, Institute for Infection and Immunity, St George's University of London, London, UK.
The Lancet Migration European Regional Hub, UK.

Alison Crawshaw (A)

The Migrant Health Research Group, Institute for Infection and Immunity, St George's University of London, London, UK.
The Lancet Migration European Regional Hub, UK.

Oumnia Bouaddi (O)

The Migrant Health Research Group, Institute for Infection and Immunity, St George's University of London, London, UK.
International School of Public Health, Mohammed VI University of Sciences and Health, Casablanca, Morocco.
The Lancet Migration European Regional Hub, UK.
Mohammed VI Center for Research and Innovation, Rabat, Morocco.

Nuria Sanchez-Clemente (N)

The Migrant Health Research Group, Institute for Infection and Immunity, St George's University of London, London, UK.
The Lancet Migration European Regional Hub, UK.

Farah Seedat (F)

The Migrant Health Research Group, Institute for Infection and Immunity, St George's University of London, London, UK.
The Lancet Migration European Regional Hub, UK.

Sam Vanderslott (S)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
NIHR Oxford Biomedical Research Centre, Oxford, Oxfordshire, UK.

Rachel Eagan (R)

The Vaccine Confidence Project, LSHTM, London, UK.

Daphne E Holt (DE)

Coalition for Life-Course Immunisation (CLCI), UK.

Yusuf Ciftci (Y)

The Migrant Health Research Group, Institute for Infection and Immunity, St George's University of London, London, UK.
The Lancet Migration European Regional Hub, UK.

Miriam Orcutt (M)

The Health and Migration Programme, World Health Organization, Geneva, Switzerland.

Holly Seale (H)

School of Population Health, University of New South Wales, Australia.

Santino Severoni (S)

The Health and Migration Programme, World Health Organization, Geneva, Switzerland.

Sally Hargreaves (S)

The Migrant Health Research Group, Institute for Infection and Immunity, St George's University of London, London, UK.
The Lancet Migration European Regional Hub, UK.

Classifications MeSH